ELEV Elevation Oncology: Company Short-Term Debts

Symbol and logo of brand Elevation Oncology (ELEV)

Elevation Oncology is implementing personalized cancer therapy by collaborating with IT developers in diagnostics to accelerate antibody creation. The market dynamics of the asset with the 0.00 indicator correlate with clinical trial successes, as the company does not yet have consistent profits. Independence from global crises and the constant demand for medical innovations turn this business into a resilient defensive asset.

ELEV elevationoncology.com Company Short-Term Loans and Borrowings (07/04/2022 - 08/02/2025)

ELEV (Elevation Oncology Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Elevation Oncology, Inc.|ELEV - Consensus Target
- company stock capitalization data:
Market Capitalization Elevation Oncology, Inc.|ELEV - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Elevation Oncology|ELEV - Accounting Value of Company|Market Cap to Net Assets Ratio elevationoncology.com|ELEV - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Elevation Oncology|ELEV - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Elevation Oncology|ELEV - Company Aggregate Debts|Debt to Book Capitalization Ratio Elevation Oncology, Inc.|ELEV - Company Long-Term Loans and Borrowings|Company Short-Term Debts Elevation Oncology|Quick Ratio elevationoncology.com
- earnings and multiples data:
ELEV - Company Net Income
Analysis of all company metrics:ELEV - Elevation Oncology, Inc.
Manufactured products of elevationoncology.com

Elevation Oncology focuses on developing targeted oncology therapies under the strict R&D expenditure control of qualified management. This indicator captures the total volume of liabilities maturing within one year, allowing for an assessment of current liquidity and default risk; analyzing the short-term debt chart helps investors correlate the biotech company's operational resilience with the overall macroeconomic backdrop.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debts CTOR|HURA - Short-Term Debt|Company Short-Term Debt Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc - Company Short-Term Debt|Aadi Bio - Company Short-Term Debts|Short-Term Debt TScan Therapeutics|CSBR (championsoncology.com) - Company Current Liabilities|XBIT (XBiotech) - Company Short-Term Debt|CVM (CEL-SCI Corp.) - Company Short-Term Debts|Company Short-Term Debts OS Therapies Inc.|Company Current Liabilities RADX (Radiopharm Theranostics)|Amount of Current Liabilities ARTV|Company Short-Term Debts ANL (Adlai Nortye)|Short-Term Debt Volume verupharma.com (VERU)|TPST - Company Short-Term Debt|Short-Term Debt Xilio Therapeutics, Inc.|renovarobio.com (RENB) - Company Short-Term Debt|Company Short-Term Indebtedness MURA|Company Current Liabilities KAPA|OKUR: Company Short-Term Loans and Borrowings|Company Short-Term Debt CytoMed Therapeutics (GDTC)|CRIS - Short-Term Debt|Company Short-Term Debt Apollomics APLM|THAR: Company Short-Term Indebtedness|Advanced Biomed Corp - Company Short-Term Debts|genprex.com (GNPX) - Company Current Liabilities|calidibio.com (CLDI) - Company Short-Term Debt|Short-Term Debt sunshinebiopharma.com (SBFM)|Company Short-Term Debt Xenetic Biosciences Inc.|Company Short-Term Debt SLRX|Company Short-Term Debt Purple Biotech (PPBT)|AONC - Short-Term Debt|Company Short-Term Debts BGNE (BeiGene)|Short-Term Indebtedness Checkpoint Therapeutics Inc.|ICAD: Company Current Liabilities|Short-Term Debt Ikena Oncology, Inc.|NTBL: Company Short-Term Debts|Short-Term Debt Viracta Therapeutics, Inc. (VIRX)|Company Short-Term Debt MorphoSys|Company Short-Term Debt NAYA|Company Short-Term Debts AAPGV